
Genomed S.A.
Research and experimental development in natural sciences and engineering
Overview
Genomed is a company that provides genetic diagnostics based on DNA sequencing and offers services for scientific research. It specializes in the analysis of any gene and also provides oligonucleotide synthesis. Additionally, Genomed is involved in personalized medicine and genome analysis.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $150,233 |
Filing timeliness
Financial statements were filed on time, on average 26 days early. All were audited by a statutory auditor.
- 202509/07/2026
- 202402/07/2025
- 202302/07/2024
- 202207/07/2023
- 202104/07/2022
- 202002/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 33.60
- High
- PLN 33.60
- Low
- PLN 32.80
- Volume
- 26
- Avg. vol.
- 59.4
- Market cap
- PLN 43.34M
- P/E ratio
- 20.76
- EPS
- PLN 1.58
- Shares outstanding
- 1.32M
- 52-week
- PLN 32.80 – 39.40
- Dividend yield
- 4.57%
- Dividend
- PLN 1.50
- Ex dividend date
- Jul 6, 2026
- ISIN
- PLGNOMD00024
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q3 2026 | USD 2.05m | USD 132.09k | USD 78.88k |
| Q2 2026 | USD 1.93m | USD 165.32k | USD 123.99k |
| Q1 2026 | USD 1.83m | USD -4.05k | USD -13.24k |
| Q4 2025 | USD 2.20m | USD 512.81k | USD 408.84k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
The sites are available in: Polish, English and Ukrainian. The sites target these markets: United Kingdom and Ukraine.
- Google Tag ManagerCloudflare
- parento.plParentoGoogle Tag Manager
- sancotest.plTest Sanco – nieinwazyjny prenatalny test genetyczny. Badania prenatalneJoomlaGoogle Tag Manager
Public procurement
82 tenders recorded as contractor: 61 national ($1,362,061) and 21 EU ($1,888,097).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 17, 2026 | Sekwencjonowanie genomowe wraz z przygotowaniem bibliotek oraz analizą bioinformatyczną - próbki w postaci materiału genetycznego (dna bakterii) | –– | Państwowy Instytut Weterynaryjny-Państwowy Instytut Badawczy | |
| Nov 5, 2026 | Supply of reagents and small laboratory equipment for the Cancer Genetic and Molecular Diagnostics Laboratory | –– | Uniwersytecki Szpital Kliniczny w Poznaniu | |
| Oct 16, 2026 | Supply of reagents, consumables and other items covered by the contract. | $9,206$9,206 | Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie |
The company is the contractor in 533 public sector contracts, worth USD 382.84k in total. They were signed with 75 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 16, 2026 | Reagent | $650.08 | Uniwersytet Mikołaja Kopernika w Toruniu | |
| Nov 13, 2026 | Sequencing service | $425.72 | Uniwersytet Mikołaja Kopernika w Toruniu | |
| Nov 13, 2026 | Supply of consumables | $432.64 | Gdański Uniwersytet Medyczny |
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2011. In 2012 it is performing 1 contract worth USD 2.16k. All its contracts were worth USD 12.99k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2012 |
|---|---|---|---|
| Outpatient specialist care | mazowieckie | 1 | USD 2.16k |
Trademarks
The company holds 8 active trademarks registered with the Polish Patent Office. The first mark was filed in 2009.
| Mark | Protected until | |
|---|---|---|
| Parento | Nov 10, 2031 | |
| genome23 | Apr 23, 2030 | |
| infano | Mar 18, 2030 | |
| MIMO | Mar 18, 2030 | |
| brovar VARIANT BROWSER | Mar 18, 2030 |
Authorized Representatives
Manner of representation
The company may be represented by two members of the management board acting jointly or by a member of the management board acting with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2007-09-12.
98 1600 1374 0003 0052 0282 6021
56 1600 1462 0006 5702 0282 6114
10 1600 1374 0003 0052 0282 6150
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 20,226PLN 20,226 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 9, 2017 | Bankruptcy notice | |
| Oct 5, 2012 | Commercial Companies Code notice |
Public aid
10 public aid cases recorded, with a total value of $857,098.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 15, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $204.6K$204,626 | Polski Fundusz Rozwoju S.A. | |
| Jul 13, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,116$2,116 | Prezydent Miasta Stołecznego Warszawy | |
| Jul 13, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,566$1,566 | Prezydent Miasta Stołecznego Warszawy |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2016-10-01 | Development of methods for non-invasive genetic diagnosis and prevention of cancer – liquid biopsy. | $525.3K$525,286 | Regional Operational Programme for the Mazowieckie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Gyncentrum sp. z o.o. | $22,506,902.40 | dnahometest.pl | ||
| Medgen Kamila Czerska I Wspólnicy sp. k. | $12,536,540.98 | medgen.pl | ||
| Histamed Dc sp. z o.o. | $5,901,162.84 | histamed.pl | ||
| Alab sp. z o.o. | $5,293,124.62 | alab.pl | ||
| Akademicki Ośrodek Diagnostyki Patomorfologicznej I Genetyczno-Molekularnej sp. z o.o. | $5,089,922.17 | aodp.pl | ||
| Testdna sp. z o.o. | $5,035,995.35 | testdna.pl | ||
| Genos sp. z o.o. | $3,695,996.40 | genos.com.pl | ||
| Warsaw Genomics S.A. | $3,563,297.87 | warsawgenomics.pl | ||
| Read-Gene S.A. | $2,163,474.84 | read-gene.com | ||
| Inngen Laboratorium Badań Genetycznych sp. z o.o. | $1,158,524.97 | inngen.pl |
Change history
| Date | Event | |
|---|---|---|
| 2015-04-24 | PKD change (Removed: 29 codes) | |
| 2011-04-12 | Share capital increase (121,900.00 PLN → 132,130.10 PLN) | |
| 2010-12-30 | Entered in the register |
FAQ
Last updated: 2026-10-04